February 27, 2024 Comments Off on New patent for Novartis drug TAFINLAR Posted in: Patent Added Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are twelve patents protecting…
The post New patent for Novartis drug TAFINLAR appeared first on Dr…
February 24, 2024 Comments Off on New patent for Allergan drug AVYCAZ Posted in: Patent Added Annual Drug Patent Expirations for AVYCAZ Avycaz is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for Allergan drug AVYCAZ appeared first on DrugPatent…